Curaleaf Holdings (CSE: CURA) this evening announced that it is making a move into European markets. The US-focused cannabis operator has agreed to acquire that of EMMAC Life Sciences, whom is reportedly the largest vertically integrated independent cannabis firm in Europe. The acquisition will see Curaleaf pay base consideration of US$286 million, which will see … Continue reading Curaleaf To Enter European Market With US$286 Million Acquisition